PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
133 hedge funds and large institutions have $385M invested in Progenics Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 43
23% less capital invested
Capital invested by funds: $501M → $385M (-$116M)
Holders
133
Holding in Top 10
1
Calls
$1.14M
Puts
$886K
Top Buyers
| 1 | +$4.52M | |
| 2 | +$2.41M | |
| 3 | +$2.28M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.9M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.81M |
Top Sellers
| 1 | -$4.57M | |
| 2 | -$4.47M | |
| 3 | -$2.53M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.85M |
| 5 |
RA
Royce & Associates
New York
|
-$1.39M |